Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-26-035500
Filing Date
2026-03-27
Accepted
2026-03-27 06:06:13
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm267639d3_defa14a.htm DEFA14A 12377
2 GRAPHIC tm267639d3_defa14aimg001.jpg GRAPHIC 151652
3 GRAPHIC tm267639d3_defa14aimg002.jpg GRAPHIC 120409
  Complete submission text file 0001104659-26-035500.txt   381638
Mailing Address 10710 MIDLOTHIAN TURNPIKE SUITE 125 NORTH CHESTERFIELD VA 23235
Business Address 10710 MIDLOTHIAN TURNPIKE SUITE 125 NORTH CHESTERFIELD VA 23235 804-379-1090
Indivior Pharmaceuticals, Inc. (Filer) CIK: 0001625297 (see all company filings)

EIN.: 412520873 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37835 | Film No.: 26800753
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)